MAGGIE FRIEDE: Open Payments
NPI 1891389706 · WAUKESHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 59 payments from 16 companies in 2025. Trend: 2023 $492 · 2024 $675 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 16 | $316 |
| Otsuka America Pharmaceutical, Inc. | 7 | $139 |
| ABBVIE INC. | 12 | $139 |
| Alkermes, Inc. | 5 | $120 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| Lundbeck LLC | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: Dyanavel XR, REXULTI, VRAYLAR, ARISTADA, INGREZZA, Auvelity, TRINTELLIX, LYBALVI.
Industry payments across WI — which companies pay providers there.
